Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

118-56-9

Homosalate

118-56-9
372-66-7

Heptaminol

372-66-7
53949-53-4

Hydroxyibuprofen-1

53949-53-4
22465-48-1

Hydroxocobalamin Acetate Vit B12 Analog

22465-48-1
64118-84-9

4'-Hydroxy Diclofenac

64118-84-9
303-33-3

Heliotrine

303-33-3
6209-65-0

Heliotrine N-oxide

6209-65-0
747-36-4

Hydroxychloroquine Sulfate

747-36-4
2880-49-1

Heraclenin

2880-49-1
125590-76-3

16beta-Hydroxystanozolol

125590-76-3
402824-96-8

Hydrochlorothiazide Impurity C

402824-96-8
5980-31-4

Hexedine

5980-31-4
123-31-9

Hydroquinone

123-31-9
87680-55-5

14-epi-Hydroxymutilin

87680-55-5
1672-63-5

Hydroxyantipyrine-4

1672-63-5
487-03-6

Harmol

487-03-6
31282-04-9

Hygromycin B

31282-04-9
15687-27-1

Ibuprofen

15687-27-1
60166-93-0

Iopamidol

60166-93-0
78649-41-9

Iomeprol

78649-41-9